Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 159

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease

Open access
Boyle, Marie, Masson, Steven, Anstee, Quentin M. · 2018 · Journal of Hepatology

Abstract

Current medical practice artificially dichotomises a diagnosis of fatty liver disease into one of two common forms: alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD). Together, these account for the majority of chronic liver diseases worldwide. In recent years, there has been a dramatic increase in the prevalence of obesity and metabolic syndrome within the general population. These factors now coexist with alcohol consumption in a substantial proportion of the population. Each exposure sensitises the liver to the injurious effects of the other; an interaction that drives and potentially accelerates the genesis of liver disease. We review the epidemiological evidence and scientific literature that considers how alcohol consumption interacts with components of the metabolic syndrome to exert synergistic or supra-additive effects on the development and progression of liver disease, before discussing how these interactions may be addressed in clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2017.11.006

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 175

  1. Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 55, 2005, 10.1002/hep.25762 · DOI · Paper page
  2. Anstee, 2016, Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease, Gastroenterology, 150, 1728, 10.1053/j.gastro.2016.01.037 · DOI · Paper page
  3. Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41 · DOI · Paper page
  4. Younossi, 2011, Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008, Clin Gastroenterol Hepatol, 9, 524, 10.1016/j.cgh.2011.03.020 · DOI · Paper page
  5. Kraus, 2015, Changes in mortality due to major alcohol-related diseases in four Nordic countries, France and Germany between 1980 and 2009: a comparative age-period-cohort analysis, Addiction, 110, 1443, 10.1111/add.12989 · DOI
  6. Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 · DOI · Paper page
  7. Hayashi, 2004, Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related, Am J Gastroenterol, 99, 76, 10.1046/j.1572-0241.2003.04013.x · DOI
  8. Wannamethee, 2003, Alcohol, body weight, and weight gain in middle-aged men, Am J Clin Nutr, 77, 1312, 10.1093/ajcn/77.5.1312 · DOI · Paper page
  9. Rissanen, 1991, Determinants of weight gain and overweight in adult Finns, Eur J Clin Nutr, 45, 419
  10. Bendsen, 2013, Is beer consumption related to measures of abdominal and general obesity? A systematic review and meta-analysis, Nutr Rev, 71, 67, 10.1111/j.1753-4887.2012.00548.x · DOI
  11. Fazzino, 2017, Heavy drinking in young adulthood increases risk of transitioning to obesity, Am J Prev Med, 53, 169, 10.1016/j.amepre.2017.02.007 · DOI
  12. Baumeister, 2005, Health Risk drinking and problematic consumption of alcohol in Pomerania: comparative analysis of the Study of Health in Pomerania (SHIP) compared with the Federal German Health and Examination Survey in 1998, Gesundheitswesen, 67, 39, 10.1055/s-2004-813829 · DOI
  13. Kotronen, 2010, Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey, BMC Public Health, 10, 237, 10.1186/1471-2458-10-237 · DOI
  14. Forgione, 2007, Alcoholic and nonalcoholic forms of fatty liver disease, Minerva Gastroenterol Dietol, 53, 83
  15. Nagata, 2007, Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis, J Toxicol Sci, 32, 453, 10.2131/jts.32.453 · DOI · Paper page
  16. Arteel, 2003, Oxidants and antioxidants in alcohol-induced liver disease, Gastroenterology, 124, 778, 10.1053/gast.2003.50087 · DOI · Paper page
  17. Clark, 2002, Nonalcoholic fatty liver disease, Gastroenterology, 122, 1649, 10.1053/gast.2002.33573 · DOI · Paper page
  18. Sakaguchi, 2011, Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress, Drug Metab Pharmacokinet, 26, 30, 10.2133/dmpk.DMPK-10-RV-087 · DOI
  19. Diehl, 2001, Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis, Alcohol Clin Exp Res, 25, 8S, 10.1111/j.1530-0277.2001.tb02368.x · DOI
  20. Sabate, 2008, High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis, Obes Surg, 18, 371, 10.1007/s11695-007-9398-2 · DOI · Paper page
  21. Cope, 2000, Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis, Gastroenterology, 119, 1340, 10.1053/gast.2000.19267 · DOI · Paper page
  22. Baker, 2010, Role of alcohol metabolism in non-alcoholic steatohepatitis, PLoS One, 5, e9570, 10.1371/journal.pone.0009570 · DOI · Paper page
  23. de Medeiros, 2015, Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis, Med Hypotheses, 85, 148, 10.1016/j.mehy.2015.04.021 · DOI
  24. Mezey, 1975, Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity, Am J Clin Nutr, 28, 1277, 10.1093/ajcn/28.11.1277 · DOI
  25. Baraona, 1986, Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats, Gastroenterology, 90, 103, 10.1016/0016-5085(86)90081-8 · DOI · Paper page
  26. Picot, 1997, Hellegouarc'h R, Gastroenterol Clin Biol, 21, 562
  27. Karahanian, 2011, Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects, Alcohol Clin Exp Res, 35, 606, 10.1111/j.1530-0277.2011.01439.x · DOI
  28. Ye, 2013, Cytochrome P4502E1 inhibitor, chlormethiazole, decreases lipopolysaccharide-induced inflammation in rat Kupffer cells with ethanol treatment, Hepatol Res, 43, 1115, 10.1111/hepr.12063 · DOI
  29. Lindros, 1983, Uninterrupted prolonged ethanol oxidation as a main pathogenetic factor of alcoholic liver damage: evidence from a new liquid diet animal model, Liver, 3, 79, 10.1111/j.1600-0676.1983.tb00854.x · DOI
  30. Kovach, 2001, Inhibition of alcohol dehydrogenase blocks enhanced Gi-protein expression following ethanol treatment in experimental hepatocellular carcinoma in vitro, Eur J Gastroenterol Hepatol, 13, 1209, 10.1097/00042737-200110000-00014 · DOI
  31. Wilson, 2006, Characterization of the human patatin-like phospholipase family, J Lipid Res, 47, 1940, 10.1194/jlr.M600185-JLR200 · DOI · Paper page
  32. Valenti, 2010, Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease, Hepatology, 51, 1209, 10.1002/hep.23622 · DOI · Paper page
  33. Tian, 2010, Variant in PNPLA3 is associated with alcoholic liver disease, Nat Genet, 42, 21, 10.1038/ng.488 · DOI · Paper page
  34. Stickel, 2011, Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians, Hepatology, 53, 86, 10.1002/hep.24017 · DOI · Paper page
  35. Trepo, 2011, Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease, J Hepatol, 55, 906, 10.1016/j.jhep.2011.01.028 · DOI
  36. Kahali, 2015, TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?, Gastroenterology, 148, 679, 10.1053/j.gastro.2015.01.038 · DOI
  37. Anstee, 2015, The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2, Semin Liver Dis, 35, 270, 10.1055/s-0035-1562947 · DOI · Paper page
  38. Heba, 2016, Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference, J Magn Reson Imaging, 43, 398, 10.1002/jmri.25006 · DOI
  39. Liangpunsakul, 2012, What should we recommend to our patients with NAFLD regarding alcohol use?, Am J Gastroenterol, 107, 976, 10.1038/ajg.2012.20 · DOI
  40. Lazo, 2014, Alcohol consumption and hepatic steatosis in the general US population, J Hepatol, 60, S13, 10.1016/S0168-8278(14)60032-5 · doi:10.1016/s0168-8278(14)60032-5
  41. O'Shea, 2010, Practice Guideline Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G, Alcoholic liver disease, Hepatology, 51, 307, 10.1002/hep.23258 · DOI · Paper page
  42. Farrell, 2007, Asia-Pacific Working Party on N. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary, J Gastroenterol Hepatol, 22, 775, 10.1111/j.1440-1746.2007.05002.x · DOI · Paper page
  43. Chokshi, 2015, J-shaped curves and public health, JAMA, 314, 1339, 10.1001/jama.2015.9566 · DOI
  44. Sato, 2012, Relationship between drinking patterns and the risk of type 2 diabetes: the Kansai Healthcare Study, J Epidemiol Community Health, 66, 507, 10.1136/jech.2010.109777 · DOI
  45. Hong, 2015, High-risk drinking is associated with a higher risk of diabetes mellitus in Korean men, based on the 2010–2012 KNHANES, Alcohol, 49, 275, 10.1016/j.alcohol.2015.02.004 · DOI
  46. Cullmann, 2012, Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population, Diabetic Med, 29, 441, 10.1111/j.1464-5491.2011.03450.x · DOI · Paper page
  47. Wechsler, 1998, Binge drinking: the five/four measure, J Stud Alcohol, 59, 122, 10.15288/jsa.1998.59.122 · DOI · Paper page
  48. Barrio, 2004, Liver disease in heavy drinkers with and without alcohol withdrawal syndrome, Alcohol Clin Exp Res, 28, 131, 10.1097/01.ALC.0000106301.39746.EB · DOI
  49. Nanji, 1985, Relationship between pork consumption and cirrhosis, Lancet, 1, 681, 10.1016/S0140-6736(85)91338-8 · DOI
  50. Nanji, 1989, Beef fat prevents alcoholic liver disease in the rat, Alcohol Clin Exp Res, 13, 15, 10.1111/j.1530-0277.1989.tb00276.x · DOI · Paper page
  51. Buettner, 2006, Defining high-fat-diet rat models: metabolic and molecular effects of different fat types, J Mol Endocrinol, 36, 485, 10.1677/jme.1.01909 · DOI · Paper page
  52. Tipoe, 2009, Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD), Histol Histopathol, 24, 1161
  53. Bergheim, 2008, Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin, J Hepatol, 48, 983, 10.1016/j.jhep.2008.01.035 · DOI · Paper page
  54. Feldstein, 2003, Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice, J Hepatol, 39, 978, 10.1016/S0168-8278(03)00460-4 · DOI · Paper page
  55. Johansen, 2006, Food buying habits of people who buy wine or beer: cross sectional study, BMJ, 332, 519, 10.1136/bmj.38694.568981.80 · DOI
  56. Barefoot, 2002, Alcoholic beverage preference, diet, and health habits in the UNC Alumni Heart Study, Am J Clin Nutr, 76, 466, 10.1093/ajcn/76.2.466 · DOI · Paper page
  57. Ruidavets, 2004, Alcohol intake and diet in France, the prominent role of lifestyle, Eur Heart J, 25, 1153, 10.1016/j.ehj.2003.12.022 · DOI
  58. Tjonneland, 1999, Wine intake and diet in a random sample of 48763 Danish men and women, Am J Clin Nutr, 69, 49, 10.1093/ajcn/69.1.49 · DOI · Paper page
  59. Kasdallah-Grissa, 2006, Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats, Alcohol Alcohol, 41, 236, 10.1093/alcalc/agh256 · DOI
  60. Ajmo, 2008, Resveratrol alleviates alcoholic fatty liver in mice, Am J Physiol Gastrointest Liver Physiol, 295, G833, 10.1152/ajpgi.90358.2008 · DOI · Paper page
  61. Kanuri, 2015, Effect of acute beer ingestion on the liver: studies in female mice, Eur J Nutr, 54, 465, 10.1007/s00394-014-0730-z · DOI
  62. Obara, 2009, Isohumulones, the bitter component of beer, improve hyperglycemia and decrease body fat in Japanese subjects with prediabetes, Clin Nutr, 28, 278, 10.1016/j.clnu.2009.03.012 · doi:10.1016/j.clnu.2009.03.012
  63. Pelletier, 2002, Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers, Alcohol Alcoholism, 37, 618, 10.1093/alcalc/37.6.618 · DOI
  64. Holst, 2017, Alcohol drinking patterns and risk of diabetes: a cohort study of 70,551 men and women from the general Danish population, Diabetologia, 60, 1941, 10.1007/s00125-017-4359-3 · DOI
  65. Purohit, 2008, Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium, Alcohol, 42, 349, 10.1016/j.alcohol.2008.03.131 · DOI · Paper page
  66. Lieber, 1965, Effects of prolonged ethanol intake: production of fatty liver despite adequate diets, J Clin Invest, 44, 1009, 10.1172/JCI105200 · DOI · Paper page
  67. Lieber, 1986, The feeding of ethanol in liquid diets, Alcohol Clin Exp Res, 10, 550, 10.1111/j.1530-0277.1986.tb05140.x · DOI · Paper page
  68. Duly, 2015, Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity, Nutr Diabetes, 5, e154, 10.1038/nutd.2015.4 · DOI
  69. Kanuri, 2016, Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice, Eur J Nutr, 55, 1153, 10.1007/s00394-015-0929-7 · DOI
  70. Hu, 1996, AdipoQ is a novel adipose-specific gene dysregulated in obesity, J Biol Chem, 271, 10697, 10.1074/jbc.271.18.10697 · DOI · Paper page
  71. McPherson, 2015, Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management, J Hepatol, 62, 1148, 10.1016/j.jhep.2014.11.034 · DOI · Paper page
  72. Bellentani, 2000, Prevalence of and risk factors for hepatic steatosis in Northern Italy, Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004 · DOI · Paper page
  73. Ruhl, 2005, Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population, Clin Gastroenterol Hepatol, 3, 1260, 10.1016/S1542-3565(05)00743-3 · DOI · Paper page
  74. Alatalo, 2008, Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index, Am J Clin Nutr, 88, 1097, 10.1093/ajcn/88.4.1097 · DOI
  75. Loomba, 2009, Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study, Aliment Pharmacol Ther, 30, 1137, 10.1111/j.1365-2036.2009.04141.x · DOI
  76. Raynard, 2002, Risk factors of fibrosis in alcohol-induced liver disease, Hepatology, 35, 635, 10.1053/jhep.2002.31782 · DOI · Paper page
  77. Ekstedt, 2009, Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease, Scand J Gastroenterol, 44, 366, 10.1080/00365520802555991 · DOI · Paper page
  78. Aberg, 2017, Binge drinking and the risk of liver events: A population-based cohort study, Liver Int, 37, 1373, 10.1111/liv.13408 · DOI
  79. Seitz, 2015, Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD), Hepatobiliary Surg Nutr, 4, 147
  80. Klatsky, 2014, Moderate alcohol intake and cancer: the role of underreporting, Cancer Causes Control, 25, 693, 10.1007/s10552-014-0372-8 · DOI
  81. Hashimoto, 2015, Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study, J Gastroenterol Hepatol, 30, 546, 10.1111/jgh.12786 · DOI
  82. Petersen, 1977, Fatty liver in patients with moderate alcohol consumption, diabetes mellitus and overweight, Scand J Gastroenterol, 12, 781, 10.3109/00365527709181720 · DOI
  83. Cotrim, 2009, Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients, Eur J Gastroenterol Hepatol, 21, 969, 10.1097/MEG.0b013e328328f3ec · DOI
  84. Dixon, 2001, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese, Gastroenterology, 121, 91, 10.1053/gast.2001.25540 · DOI · Paper page
  85. Kwon, 2014, Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease, Liver Int, 34, 129, 10.1111/liv.12230 · DOI
  86. Dunn, 2012, Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD), J Hepatol, 57, 384, 10.1016/j.jhep.2012.03.024 · DOI · Paper page
  87. Hagstrom, 2017, Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease, Scand J Gastroenterol, 52, 159, 10.1080/00365521.2016.1239759 · DOI
  88. Mukamal, 2006, Alcohol consumption and self-reported sunburn: a cross-sectional, population-based survey, J Am Acad Dermatol, 55, 584, 10.1016/j.jaad.2006.04.033 · DOI
  89. Fillmore, 1998, Alcohol consumption and mortality. I. Characteristics of drinking groups, Addiction, 93, 183, 10.1046/j.1360-0443.1998.9321834.x · DOI
  90. La Vecchia, 1995, Prevalence of chronic diseases in alcohol abstainers, Epidemiology, 6, 436, 10.1097/00001648-199507000-00021 · DOI
  91. Suh, 2015, Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index, Cancer, 121, 3818, 10.1002/cncr.29577 · DOI
  92. Lazo, 2013, Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994, Am J Epidemiol, 178, 38, 10.1093/aje/kws448 · DOI · Paper page
  93. Argo, 2009, Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis, J Hepatol, 51, 371, 10.1016/j.jhep.2009.03.019 · DOI · Paper page
  94. Longato, 2012, Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease, Oxid Med Cell Longev, 2012, 479348, 10.1155/2012/479348 · DOI
  95. Stepanova, 2010, Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study, Gut, 59, 1410, 10.1136/gut.2010.213553 · DOI · Paper page
  96. Bhagat, 2009, Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis vs. patients with cirrhosis due to alcoholic liver disease, Liver Transpl, 15, 1814, 10.1002/lt.21927 · DOI · Paper page
  97. Yan, 2012, Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease, World J Hepatol, 4, 110, 10.4254/wjh.v4.i4.110 · DOI
  98. Finelli, 2013, What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?, World J Gastroenterol, 19, 802, 10.3748/wjg.v19.i6.802 · DOI · Paper page
  99. Rogers, 2008, Adiponectin and alcoholic fatty liver disease, IUBMB Life, 60, 790, 10.1002/iub.124 · DOI
  100. Yi, 2016, Impact of alcohol consumption and body mass index on mortality from nonneoplastic liver diseases, upper aerodigestive tract cancers, and alcohol use disorders in Korean older middle-aged men: Prospective cohort study, Medicine, 95, e4876, 10.1097/MD.0000000000004876 · DOI
  101. Kawamura, 2016, Effects of alcohol consumption on hepatocarcinogenesis in japanese patients with fatty liver disease, Clin Gastroenterol Hepatol, 14, 597, 10.1016/j.cgh.2015.11.019 · DOI
  102. Loomba, 2010, Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men, Clin Gastroenterol Hepatol, 8, 891, 10.1016/j.cgh.2010.06.027 · DOI
  103. Singal, 2014, The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis, Am J Gastroenterol, 109, 325, 10.1038/ajg.2013.476 · DOI · Paper page
  104. Salameh, 2015, PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease, Am J Gastroenterol, 110, 846, 10.1038/ajg.2015.137 · DOI
  105. Liu, 2014, Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma, J Hepatol, 61, 75, 10.1016/j.jhep.2014.02.030 · DOI · Paper page
  106. Marrero, 2005, Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma, J Hepatol, 42, 218, 10.1016/j.jhep.2004.10.005 · DOI · Paper page
  107. Adams, 2017, Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases, Gut, 66, 1138, 10.1136/gutjnl-2017-313884 · DOI · Paper page
  108. Pietraszek, 2010, Alcohol and type 2 diabetes. A review, Nutr Metab Cardiovasc Dis, 20, 366, 10.1016/j.numecd.2010.05.001 · DOI · Paper page
  109. Sinn, 2014, Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease, Atherosclerosis, 234, 270, 10.1016/j.atherosclerosis.2014.03.001 · DOI
  110. Klatsky, 2009, Alcohol and cardiovascular diseases, Expert Rev Cardiovasc Ther, 7, 499, 10.1586/erc.09.22 · DOI
  111. Marks, 2012, Calorie and alcohol consumption in nonalcoholic fatty liver disease, Eur J Gastroenterol Hepatol, 24, 527, 10.1097/MEG.0b013e3283514edb · DOI
  112. Bell, 1994, Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department, Alcohol Clin Exp Res, 18, 1103, 10.1111/j.1530-0277.1994.tb00088.x · DOI
  113. Seitz, 2006, Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase, Am J Clin Nutr, 83, 1252, 10.1093/ajcn/83.6.1252 · DOI
  114. Imbert-Bismut, 2001, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, Lancet, 357, 1069, 10.1016/S0140-6736(00)04258-6 · DOI · Paper page
  115. Nalpas, 1986, Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit, Hepatology, 6, 608, 10.1002/hep.1840060410 · DOI
  116. Williams, 1988, Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis, Gastroenterology, 95, 734, 10.1016/S0016-5085(88)80022-2 · DOI · Paper page
  117. Nyblom, 2004, High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking, Alcohol Alcohol, 39, 336, 10.1093/alcalc/agh074 · DOI · Paper page
  118. McPherson, 2010, Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease, Gut, 59, 1265, 10.1136/gut.2010.216077 · DOI · Paper page
  119. Angulo, 2007, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD, Hepatology, 45, 846, 10.1002/hep.21496 · DOI · Paper page
  120. Vallet-Pichard, 2007, FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest, Hepatology, 46, 32, 10.1002/hep.21669 · DOI · Paper page
  121. Mitchell, 2014, Absorption and peak blood alcohol concentration after drinking beer, wine, or spirits, Alcohol Clin Exp Res, 38, 1200, 10.1111/acer.12355 · DOI
  122. Chrostek, 2012, The diagnostic power of direct carbohydrate-deficient transferrin immunoassay in alcoholics. Absolute or relative values?, Alcohol, 46, 69, 10.1016/j.alcohol.2011.08.010 · DOI
  123. Fagan, 2013, BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin, Alcohol Clin Exp Res, 37, 1771, 10.1111/acer.12143 · DOI
  124. Stewart. Alcohol. Clin Exp Res 2013;1:150–155. · DOI
  125. Staufer, 2011, Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption, Hepatology, 54, 1640, 10.1002/hep.24596 · DOI
  126. Coulton, 2006, Opportunistic screening for alcohol use disorders in primary care: comparative study, BMJ, 332, 511, 10.1136/bmj.38743.421574.7C · DOI
  127. Hagedorn, 2007, Does gastric bypass alter alcohol metabolism?, Surg Obes Related Dis, 3, 543, 10.1016/j.soard.2007.07.003 · DOI · Paper page
  128. Maluenda, 2010, Alcohol absorption modification after a laparoscopic sleeve gastrectomy due to obesity, Obes Surg, 20, 744, 10.1007/s11695-010-0136-9 · DOI
  129. Yoder, 2017, How do individuals develop alcohol use disorder after bariatric surgery? A grounded theory exploration, Obes Surg
  130. Mitchell, 2001, Long-term follow-up of patients' status after gastric bypass, Obes Surg, 11, 464, 10.1381/096089201321209341 · DOI · Paper page
  131. Ertelt, 2008, Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set, Surg Obes Related Dis, 4, 647, 10.1016/j.soard.2008.01.004 · DOI · Paper page
  132. King, 2012, Prevalence of alcohol use disorders before and after bariatric surgery, JAMA, 307, 2516, 10.1001/jama.2012.6147 · DOI · Paper page
  133. King, 2017, Alcohol and other substance use after bariatric surgery: prospective evidence from a U.S. multicenter cohort study, Surg Obesity Related Dis, 13, 1392, 10.1016/j.soard.2017.03.021 · DOI · Paper page
  134. Ostlund, 2013, Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery, JAMA Surg, 148, 374, 10.1001/jamasurg.2013.700 · DOI
  135. Conason, 2013, Substance use following bariatric weight loss surgery, JAMA Surg, 148, 145, 10.1001/2013.jamasurg.265 · DOI · Paper page
  136. Wee, 2014, High-risk alcohol use after weight loss surgery, Surg Obes Related Dis, 10, 508, 10.1016/j.soard.2013.12.014 · DOI
  137. Barry, 2009, Associations between body mass index and substance use disorders differ by gender: results from the National Epidemiologic Survey on Alcohol and Related Conditions, Addict Behav, 34, 51, 10.1016/j.addbeh.2008.08.008 · DOI
  138. Barry, 2008, Gender differences in associations between body mass index and DSM-IV mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions, Ann Epidemiol, 18, 458, 10.1016/j.annepidem.2007.12.009 · DOI · Paper page
  139. Scott, 2008, Obesity and mental disorders in the general population: results from the world mental health surveys, Int J Obes, 32, 192, 10.1038/sj.ijo.0803701 · DOI · Paper page
  140. Abizaid, 2006, Thoughts for food: brain mechanisms and peripheral energy balance, Neuron, 51, 691, 10.1016/j.neuron.2006.08.025 · DOI
  141. Volkow, 2000, Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex, Cereb Cortex, 10, 318, 10.1093/cercor/10.3.318 · DOI · Paper page
  142. Kiefer, 2001, Leptin: a modulator of alcohol craving?, Biol Psychiatry, 49, 782, 10.1016/S0006-3223(01)01081-2 · DOI
  143. 2009, CDC. Cigarette smoking among adults and trends in smoking cessation -United States 2008, MMWR Morb Mortal Wkly Rep, 58, 1227
  144. Yeh, 2010, Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study, Ann Intern Med, 152, 10, 10.7326/0003-4819-152-1-201001050-00005 · DOI · Paper page
  145. Janzon, 2004, Changes in blood pressure and body weight following smoking cessation in women, J Intern Med, 255, 266, 10.1046/j.1365-2796.2003.01293.x · DOI
  146. Karsenty, 1985, Paradoxical effect of ethanol on liver lipogenesis in the genetically-obese Zucker rat, Br J Nutr, 54, 15, 10.1079/BJN19850087 · doi:10.1079/bjn19850087
  147. Carmiel-Haggai, 2003, Binge ethanol exposure increases liver injury in obese rats, Gastroenterology, 125, 1818, 10.1053/j.gastro.2003.09.019 · DOI
  148. Olleros, 2008, Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines, Cytokine, 44, 118, 10.1016/j.cyto.2008.07.001 · DOI
  149. Wang, 2009, Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease, Hepatology, 50, 453, 10.1002/hep.22978 · DOI
  150. Wang, 2010, Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats, Alcohol Clin Exp Res, 34, 567, 10.1111/j.1530-0277.2009.01122.x · DOI
  151. Gabele, 2011, A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis, Alcohol Clin Exp Res, 35, 1361, 10.1111/j.1530-0277.2011.01472.x · DOI
  152. Xu, 2011, Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK, J Hepatol, 55, 673, 10.1016/j.jhep.2010.12.034 · DOI · Paper page
  153. Everitt, 2013, Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice, Am J Physiol Gastrointest Liver Physiol, 304, G38, 10.1152/ajpgi.00309.2012 · DOI
  154. Nascimento, 2013, Aggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in rats, Hepatobiliary Surg Nutr, 2, 252
  155. Duryee, 2014, Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis, Am J Physiol Gastrointest Liver Physiol, 306, G208, 10.1152/ajpgi.00124.2013 · DOI
  156. Minato, 2014, Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis, Mol Med, 20, 490, 10.2119/molmed.2014.00048 · DOI
  157. Alwahsh, 2014, Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats, PLoS One, 9, e104220, 10.1371/journal.pone.0104220 · DOI
  158. Chang, 2015, Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1, Hepatology, 62, 1070, 10.1002/hep.27921 · DOI · Paper page
  159. Song, 2016, Chronic alcohol consumption causes liver injury in high-fructose-fed male mice through enhanced hepatic inflammatory response, Alcohol Clin Exp Res, 40, 518, 10.1111/acer.12994 · DOI
  160. Lau, 2015, The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women, Aliment Pharmacol Ther, 41, 467, 10.1111/apt.13067 · DOI
  161. Suzuki, 2007, Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia, Am J Gastroenterol, 102, 1912, 10.1111/j.1572-0241.2007.01274.x · DOI
  162. Dunn, 2008, Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease, Hepatology, 47, 1947, 10.1002/hep.22292 · DOI · Paper page
  163. Gunji, 2009, Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population, Am J Gastroenterol, 104, 2189, 10.1038/ajg.2009.361 · DOI
  164. Yamada, 2010, Alcohol drinking may not be a major risk factor for fatty liver in Japanese undergoing a health checkup, Dig Dis Sci, 55, 176, 10.1007/s10620-008-0693-0 · DOI
  165. Shen, 2010, A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels, Eur J Gastroenterol Hepatol, 22, 820, 10.1097/MEG.0b013e3283328b86 · DOI
  166. Hiramine, 2011, Alcohol drinking patterns and the risk of fatty liver in Japanese men, J Gastroenterol, 46, 519, 10.1007/s00535-010-0336-z · DOI
  167. Moriya, 2011, Alcohol consumption appears to protect against non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 33, 378, 10.1111/j.1365-2036.2010.04520.x · DOI
  168. Hamaguchi, 2012, Protective effect of alcohol consumption for fatty liver but not metabolic syndrome, World J Gastroenterol, 18, 156, 10.3748/wjg.v18.i2.156 · DOI
  169. Wong, 2012, Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography, Gut, 61, 409, 10.1136/gutjnl-2011-300342 · DOI · Paper page
  170. Taniai, 2012, Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease, Hepatol Res, 42, 359, 10.1111/j.1872-034X.2011.00935.x · DOI
  171. Moriya, 2015, Roles of alcohol consumption in fatty liver: a longitudinal study, J Hepatol, 62, 921, 10.1016/j.jhep.2014.11.025 · DOI
  172. Takahashi, 2015, Biphasic effect of alcohol intake on the development of fatty liver disease, J Gastroenterol, 50, 1114, 10.1007/s00535-015-1058-z · DOI
  173. Dunn, 2012, The interaction of rs738409, obesity, and alcohol: a population-based autopsy study, Am J Gastroenterol, 107, 1668, 10.1038/ajg.2012.285 · DOI
  174. Ascha, 2010, The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, Hepatology, 51, 1972, 10.1002/hep.23527 · DOI · Paper page
  175. Pais, 2015, Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants, Clin Gastroenterol Hepatol, 13, 992, 10.1016/j.cgh.2014.10.011 · DOI

Cited by

See all 159

Metadata

Authors
Boyle, M., Masson, S., & Anstee, Q. M.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2018-02
Volume
68
Issue
2
Pages
251-267
ISSN
0168-8278 (ISSN-L)
OpenAlex
W2766791134
Cited by
159
References
43
FWCI
9.46
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. https://app.cochat.ai/papers/10.1016/j.jhep.2017.11.006
The paper
Boyle, M., Masson, S., & Anstee, Q. M. (2018). The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2017.11.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.